Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL: A Phase 4 Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal

Trial Profile

A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL: A Phase 4 Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 22 May 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bupivacaine (Primary) ; Morphine
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms IMPROVE-IR
  • Sponsors Pacira Pharmaceuticals
  • Most Recent Events

    • 19 May 2015 According to a Pacira Pharmaceuticals media release, data from this study were presented at the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
    • 19 May 2015 According to a Pacira Pharmaceuticals media release, data from this study were presented at the annual meeting of the World Congress of Enhanced Recovery after Surgery and Perioperative Medicine, Plastic Surgery Research Council (PSRC).
    • 26 Feb 2013 Official title amended as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top